SCA's presentation from UBS European Conference in London, held by Lennart Persson, CFO and Executive Vice President, Head of Finance, SCA.

1. UBS conference
Lennart Persson, CFO

2. SCA Group
 Net sales of SEK 91bn*
 37,000 employees
 Sales in more than 100 countries
 Leading global hygiene company
 #1 or #2 positions in close to 80 countries
 Strong brands;
TEN and Tork are leading global billion-euro
brands for Incontinence care and AFH tissue
 Europe’s largest private forest owner
 Europe’s second-largest sawmill company
 Several of the world’s most prestigious
sustainability awards
* 2011 sales adjusted for closed transactions
2 November 2012

3. Transforming SCA
 Divestment of the Packaging business, excluding the two kraftliner mills
 Acquisition of Georgia-Pacific’s European tissue operations
 Acquisitions in emerging markets
 Everbeauty in Asia
 Pro Descart in Brazil
 San Saglik and Komili(50%) in Turkey
 Joint venture in Australia/New Zealand
 Divestment of Aylesford Newsprint
 Efficiency program
 Leadership and culture
3 November 2012

4. SCA Group
9 months 2012 sales and EBIT by Business Area
Sales by Business Area EBIT by Business Area
Forest Products Personal Care Forest Products Personal Care
22% 16%
30% 35%
48% 49%
Tissue Tissue
4 November 2012

5. SCA Group
Sales by Product Category
Personal Care Tissue
Feminine care
15% Incontinence products
AFH tissue
38%
54%
31% 62%
Baby diapers
73% branded
Consumer tissue
52% branded
5 November 2012

6. SCA Group
Hygiene business is growing
% of net sales
~20%*
54% 40%
46% 60% ~80%*
Forest Products and Hygiene products
Packaging (Personal Care and Tissue)
6 November 2012

7. Leading Market positions
Globally and regionally
Value market positions
North America Nordic region
Incontinence products: 2 Incontinence products: 1 Europe
AFH tissue: 3 Tissue: 1
Baby diapers: 1
AFH tissue: 1 Incontinence products 1
Mexico Baby diapers: 3
Consumer tissue: 2
Incontinence products: 1 Feminine care 3
Feminine care 2
Feminine care: 1 Private forest owners: 1
Consumer tissue 2 Solid-wood products: 2
AFH tissue: 3
Baby diapers: 3
Asia
Incontinence products: 1
Colombia Globally
Incontinence products: 1
Incontinence products: 1
Feminine care: 1
AFH tissue: 1
Tissue: 1
Consumer tissue: 2
Baby diapers 2
7 November 2012

8. SCA Group’s Priorities
EFFICIENCY INNOVATION GROWTH
SUSTAINABILITY
8 November 2012

9. Efficiency
 Restructuring program in baby diapers
in Europe completed
 2011 Efficiency program
 Annual cost saving: EUR 80m
 Higher machine efficiency and reduced CAPEX
 Cost and productivity program
 Annual cost saving: EUR 300m
 Georgia-Pacific synergies
 Annual cost saving: EUR 125m
 Energy efficiency program
 Annual cost saving: EUR 70m
 Efficiency improvements in Forest Products
 Investments in upgrades and new capacity
9 November 2012

10. Cost and Productivity program*
Key actions
 Manufacturing
 Blueprint implementation Cost savings
 Asset utilization improvements
 Best practice sharing
SG&A
 Sourcing
 World-class sourcing processes Logistics 12%
 Leverage global scale 6% Manufacturing
 Consolidation of suppliers 43%
 Logistics
 Optimize warehouse footprint 39%
 Lower transportation costs
Sourcing
 Working capital management
 SG&A
 Fewer layers in the organization
 Clear roles and responsibilities, no overlaps
 Center-led support model
Total annual cost savings: EUR 300m
Related restructuring costs: EUR 100m
Headcount reduction: approx. 1,500
* Excluding Georgia-Pacific acquisition
10 November 2012

11. Georgia-Pacific Acquisition
Strengthens our no.1 position
 Perfect strategic fit
 Substantial synergies
 Strengthens our geographic presence in Europe
 Strong innovation portfolio
 Strengthens our branded portfolio
11 November 2012

12. Georgia-Pacific Acquisition
Synergies
Supply chain synergies
Cost synergies
Cost synergies
 Manufacturing excellence and best
practice
Support and
 Footprint optimization overhead
 Scale effects raw materials 25%
 Logistics optimization 60% Supply chain
15%
Sales and Marketing Sales and
Marketing
 S&M organization consolidation
 A&P efficiency
Support and overhead
 Consolidation of support functions
Total annual cost synergies: EUR 125m
Related restructuring costs: EUR 130m
12 November 2012

13. Innovation drives Profitable growth
Strengthens market positions and profitability
 Meet changing demands and requirements
 Create long-term, profitable differentiation
 Strengthen market positions
 Build stronger brands
 Drive growth
13 November 2012

14. Market Drivers
Good growth opportunities
 Global population growth
 An aging population
 Increased market penetration
 Higher disposable income
 Customers and consumers demand
more comfort and sustainability
14 November 2012

15. Global Hygiene Products Market
Increased penetration and aging and growing population
Personal Care
Tissue
2010 2017
15 November 2012

16. Hygiene Products
High potential in markets with low penetration
Usage of Hygiene products
Units/capita/year Units/child/year Units/woman/year Kg/capita/year
North America Western Europe Eastern Europe Latin America Asia
16 November 2012

17. Growth
High growth in Emerging markets
Q3 2012
Emerging markets sales growth:
Personal Care: +26%*
Tissue: +20%*
% of Personal Care sales** % of Tissue sales**
Emerging markets 16% Emerging markets
37%
Mature markets Mature markets
* Adjusted for exchange rate movements
** Q3 2012
17 November 2012

18. SCA’s Market Priority
Mature markets Established Not-present
 Improve profitability emerging markets emerging markets
 Increased cash flow  Profitable growth  Selected entry
generation  Strengthen market
 Strengthen market positions
positions  Category expansion
 Category expansion
18 November 2012

19. Financial Targets
Group
ROCE** 13%
Debt/Equity 0.70
Debt payment capacity above 35%
Dividend policy 1/3 of cash flow from current operations
Business areas
Sales growth* ROCE**
Personal Care 5-7% 30%
Tissue 3-4% 15%
Forest Products in line with market in top quartile
* Annual organic sales growth
** Return on capital employed
19 November 2012

20. IR Contacts:
Johan Karlsson, VP Investor Relations Louise Tjeder, Director Investor Relations
Tel: +46 8 788 51 30 Tel: +46 8 788 51 62
Email: ir@sca.com Website: www.sca.com